Published on 18 Nov 2022 on Simply Wall St. via Yahoo Finance
The recent 13% drop in Enzo Biochem, Inc.'s (NYSE:ENZ) stock could come as a blow to insiders who purchased US$3.1m worth of stock at an average buy price of US$3.23 over the past 12 months. This is not good as insiders invest based on expectations that their money will appreciate over time. However, as a result of recent losses, their original investment is now worth only US$2.0m.
While insider transactions are not the most important thing when it comes to long-term investing, logic dictates you should pay some attention to whether insiders are buying or selling shares.
Check out our latest analysis for Enzo Biochem